metastatic melanoma
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
metastatic melanoma
Jun 20, 2024, 14:24 |
Insight
Cancer Research Institute raises $35,635.10 to support cancer research
Cancer Research Institute (CRI) shared on LinkedIn: “On Thursday, June 13, the Cancer Research Institute…
Jun 12, 2024, 14:31 |
Blog
Cancer Research Institute - The Importance of Immune 2 Cancer Day
Cancer Research Institute shared a post on LinkedIn: "'The importance of Immune 2 Cancer Day is…
Jun 10, 2024, 12:49 |
Dialogues
ASCO24 Updates: New Hope for Advanced Melanoma Patients: TIL Therapy Explained
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
May 25, 2024, 10:05 |
Insight
Marco Donia: The Role of PD-L1 Assessment in Dual Checkpoint Inhibition for Melanoma
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: "The…
Mar 10, 2024, 15:30 |
Blog
Lola Fashoyin-Aje: An amazing first week at the FDA Center for Biologics Evaluation and Research
Lola Fashoyin-Aje, Director, Office of Clinical Evaluation (Cell and Gene Therapies) at FDA, shared a post on…
Feb 23, 2024, 17:40 |
Drugs
Nicole Verdun: We granted accelerated approval for Amtagvi (lifileucel), manufactured by Iovance Biotherapeutics
Nicole Verdun, Super Office Director at FDA, recently posted on LinkedIn: "I am pleased to…
Dec 11, 2023, 11:35 |
Blog
Monica Bertagnolli assisted Stephanie Goff in a surgery as part of a clinical trial at NIH Clinical Center
Monica M. Bertagnolli shared on X/Twitter: "I recently assisted Dr. Stephanie Goff with a surgery…
All:
7
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube